- Info
- Insider Trading
- Financials
- Holders: LYEL, LYEL
Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL)
CUSIP: 55083R104
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 19,277,111
- Total 13F shares
- 79,701,853
- Share change
- +79,701,853
- Total reported value
- $1,294,200,800
- Price per share
- $16.24
- Number of holders
- 52
- Value change
- +$1,294,200,800
- Number of buys
- 52
Quarterly Holders Quick Answers
What is CUSIP 55083R104?
CUSIP 55083R104 identifies LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q3 2021
Recent filing periods for CUSIP 55083R104:
Top shareholders of LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GSK plc |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
30,253,189
|
$68,977,271 | — | 21 Jun 2021 |
Institutional Holders of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) as of Q2 2021
As of 30 Jun 2021,
Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
79,701,853 shares.
The largest 10 holders included
MWG Management Ltd., Apoletto Ltd, Foresite Capital Management IV, LLC, Alphabet Inc., SB Management Ltd, PRICE T ROWE ASSOCIATES INC /MD/, SC CHINA HOLDING Ltd, HHLR ADVISORS, LTD., VANGUARD GROUP INC, and Board of Trustees of The Leland Stanford Junior University.
This page lists
52
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q3 2025 Across Filers
Q3 2025 holders
2
Q2 2021 holders
52
Holder diff
50
| Investor | Q3 2025 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.